Sidewinder Therapeutics is a startup based in the United States, 1 tracked investor.
Based in the United States, Sidewinder Therapeutics is a startup. Brouky records 1 investor associated with the company.
Sidewinder Therapeutics develops bispecific antibody-drug conjugates that target two receptor complexes on cancer cells simultaneously to increase tumor specificity and enhance delivery of toxic payloads for treatment of cancers with limited therapeutic options.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.